The massive increase in automated testing combined with manufacturing limitations, both due to COVID-19, the life science industry has experienced a shortage in disposable pipette tips. As a result, scientists are switching to alternative disposable pipette tip brands or are including tip washing in their daily protocol. Unfortunately, without properly qualifying either approach the assays often suffer from poor data quality, lot to lot variability, or sporadic failures.
By implementing a tip verification program, you can ensure the tips meet your specifications before embarking on a large screening or diagnostic testing campaign. This webinar will review the attributes that affect disposable pipette quality during the manufacturing process and how to design an effective tip performance verification program. Our approach takes advantage of the MVS and provides you with quantitative data allowing you to make informed decisions. By tracking this data across different lots or tip manufacturers, failures can be avoided for longer term screening campaigns or continuous diagnostic testing.
What you will learn:
Dr. Nathaniel Hentz is currently Director, Scientific Market Development at Artel. Prior to that, Dr. Hentz served as Assistant Director of the BTEC Analytical Lab at North Carolina State University for almost 11 years. In that role, he taught both undergraduate and graduate level courses as well as industry short courses focused on biopharmaceutical assay development and validation. Dr. Hentz’s tenure in the HTS industry includes nearly two years supporting the automated screening systems within the Lead Discovery group at Bristol-Myers Squibb in Connecticut and seven years developing screens at Eli Lilly RTP Laboratories in North Carolina.